SAN ANTONIO, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BioBridge Global, founded in 2012, is a mid-sized nonprofit in the Health Care sector that reported $45.3M in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $43.2M left a modest 5% surplus.
BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION), and Helping Hearts Fund, EACH OF WHICH IS A 501(C)(3) ORGANIZATION, BY (CONTINUED ON SCHEDULE O)
BIOBRIDGE GLOBAL IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, THE BLOOD & TISSUE...
BIOBRIDGE GLOBAL IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION), and Helping Hearts Fund BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THE CHARITABLE MISSION AND PURPOSES OF STBTC, QUALTEX, GENCURE, AND THE FOUNDATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $45,332,595 | $40,649,086 | +0.1% |
| Expenses | $43,230,038 | $39,281,452 | +0.1% |
| Net Income | $2,102,557 | $1,367,634 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GABRIELE NIEDERAUER PHD | CHAIR | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| JAMES ROSENBLATT JD | SECRETARY | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| JEANNIE FRAZIER | TREASURER | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| MARTIN J LANDON | EX-OFFICIO DIR/CEO | 49.0 |
Officer
Director
|
$1,088,471 | $45,312 | $1,133,783 |
| MICHAEL KREAGER JD | CHAIR EMERITUS/ASST SECRETARY | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| RANDI BROSTERMAN HUTCHENS | VICE-CHAIR | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| STEVEN BROOK JD | IMMEDIATE PAST CHAIR | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| AL RAJWANI | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| BARBARA R HOLCOMB RN BSN MSN | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| CHARLES J LERNER MD FSHEA FACP | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| DONALD H JENKINS MD FACS | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| J CHARLENE DAVIS PHD | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| JENNA SAUCEDO-HERRERA | DIRECTOR | 1.0 |
Director
|
$0 | $0 | $0 |
| JOHN FEIK | DIRECTOR EMERITUS | 1.0 |
Director
|
$0 | $0 | $0 |
| KENNETH GINDY JD | DIRECTOR EMERITUS | 1.0 |
Director
|
$0 | $0 | $0 |
| KENNETH P TREVETT JD | DIRECTOR EMERITUS | 1.0 |
Director
|
$0 | $0 | $0 |
| THOMAS M MCNISH MD MPH | DIRECTOR EMERITUS | 1.0 |
Director
|
$0 | $0 | $0 |
| ADRIENNE MENDOZA | SVP, COO STBTC | 1.0 |
Officer
|
$0 | $28,544 | $423,265 |
| GRANVILLE BETTON | SVP, TALENT AND PERFORMANCE MGMT | 50.0 |
Officer
|
$295,970 | $48,440 | $344,410 |
| JOHN WILLIAM YOUNGDAHL | SVP/CFO | 50.0 |
Officer
|
$383,663 | $37,134 | $420,797 |
| MARK EDWARD FITE | SVP, COO, QUALTEX | 1.0 |
Officer
|
$0 | $40,003 | $476,889 |
| RACHEL-LOUISE BEDDARD | SVP/CHIEF MEDICAL OFFICER | 50.0 |
Officer
|
$427,724 | $55,678 | $483,402 |
| THOMAS SCOTT JONES | SVP, CHIEF SCIENTIFIC OFFICER | 50.0 |
Officer
|
$357,318 | $45,581 | $402,899 |
| WILLIAM RICHEY WYATT | SVP/GEN COUNSEL & CHIEF COMPLIANCE OFFICER | 50.0 |
Officer
|
$505,643 | $55,728 | $561,371 |
| CHRISTOPHER JOHNSON | VP, SUPPLY CHAIN & SUPPORT SERVICES | 50.0 |
Key Emp
|
$261,470 | $49,630 | $311,100 |
| JOSE MURILLO | VP. INFORMATION TECHNOLOGY | 50.0 |
Key Emp
|
$311,641 | $54,747 | $366,388 |
| ANAND SRINIVASAN | VP, TECHNOLOGY & INNOVATIONS | 50.0 |
Highest
|
$324,473 | $15,803 | $340,276 |
| Benjamin Lopez | Sr. Director, Finance & Accounting | 50.0 |
Highest
|
$229,935 | $22,583 | $252,518 |
| CHRISTIE MALONE | SR. DIRECTOR, CUSTOM SOLUTIONS & SALES SUP | 25.0 |
Highest
|
$232,978 | $30,546 | $263,524 |
| EMMANUEL CASASOLA | EXECUTIVE DIRECTOR, GLOBAL QUALITY | 50.0 |
Highest
|
$237,123 | $28,301 | $265,424 |
| SOPHIE BARDY | VP MARKETING | 50.0 |
Highest
|
$298,853 | $56,361 | $355,214 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $45,332,595 | $43,230,038 | $83,238,285 | $2,102,557 |
| 2023 | $40,649,086 | $39,281,452 | $75,173,327 | $1,367,634 |
| 2022 | $36,640,731 | $34,844,828 | $69,766,084 | $1,795,903 |
| 2021 | $35,430,455 | $31,920,674 | $72,557,364 | $3,509,781 |
| 2020 | $30,301,028 | $30,935,950 | $70,894,449 | $-634,922 |
| 2019 | $27,210,328 | $27,068,715 | $65,163,575 | $141,613 |
| 2018 | $29,878,904 | $22,541,414 | $58,953,278 | $7,337,490 |
Compare BioBridge Global with other nonprofits in Texas and across the country.